Quest PharmaTech Inc.QPT.V

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · questpharmatech.com

Quest PharmaTech Inc. is a Canadian pharmaceutical company headquartered in Edmonton, Alberta, focused on developing antibody-based immunotherapeutic products for cancer treatment. The company's lead candidate MAb AR9.6 targets MUC16 antigens for potential treatment of pancreatic, colon, leukemia, ovarian, and breast cancers, and it maintains ownership interests in joint ventures including OncoVent in China.

Key ratios

ROA

-2.0%TTM

2025 -2.2%2024 -3.2%2023 -0.9%

ROE

-0.4%TTM

2025 -8.1%2024 -12.4%2023 -111.8%

Recent news

Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis 2026-05-29 · GlobeNewswire

Track QPT.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer